Fundraising Fox

Neuralight

Tel Aviv, IL · Founded 2021 · 29 employees on LinkedIn · 15 known investors

Find your way into Neuralight

558 people in our graph share verified history with the Neuralight team — schools, employers, funds. One of them is your warm intro.

Tobi Cokerunlockedknows Gil Shklarski · together at Stealth (overlapped)
knows the team · via Ben-Gurion University of the Negev
×2knows the team · via Thirty Madison
×2knows the team · via Flatiron Health
×2knows the team · via Tel Aviv University
×4knows the team · via Stealth

NeuraLight develops AI-powered digital biomarkers for neurological diseases including Alzheimer's, Parkinson's, and multiple sclerosis. The company uses signal processing and computer vision to enable clinical assessment and disease monitoring for healthcare providers and medical institutions.

AI & Machine LearningBiotechHealthtechMedical Devices

Founders & leadership

Neuralight was founded in 2021 by Edmund Ben-Ami, Edmund Benami, and Gil Shklarski.

EBEdmund Ben-Ami
Edmund Ben-AmiinCo-Founder & CEOFounder of NeuraLight, which uses signal processing and computer vision to develop AI-powered digital biomarkers for neurological diseases including Alzheimer's, Parkinson's, and multiple sclerosis.
EB
Edmund BenamiFounder
GSGil Shklarski
Gil Shklarskiin𝕏Investor, Board Observer, Scientific Co-FounderGeneral Partner at Operator LP
E
Eddy
GGil
Gilin𝕏General Partner at Operator LP

Board

PT
Prof. Thomas Südhof
PO
Prof. Olivier Rascol

Investors · 15

MS&AD Ventures✓ verifiedMenlo Park · $500K – $3M
Breyer CapitalAustin · $500K – $10M
Koch Disruptive TechnologiesSan Francisco
Samsung NextSan Jose · $100K – $5M
Kli CapitalreportedChamplain · $500K – $2M
Operator PartnersreportedNew York
Tuesday Capitalreported · 2 sourcesSan Francisco
VSC VenturesreportedSan Francisco · $500K – $750K

Also in the syndicate · 7

KliKock Disruptive TechnologiesleadMSADMSAD.vcleadNEXTSamsungTuesday

Funding

SEC filings, press & company announcements

$30.5M disclosed across 2 rounds · 2021–2022

Source: company announcements and press reports — follow each round's link for the claim.

Competitors · 4

by search overlap
Neuron234 shared keywordsNeuron23 is a biotech company using data science, human genetics, and functional genomics to develop precision medicines and companion diagnostics for neurodegenerative diseases, starting with an LRRK2 program for Parkinson's disease. It aims to match patient subsets defined by genetic drivers with targeted therapies for conditions such as Parkinson's and Alzheimer's.
Neuralink4 shared keywordsNeurotechnology company developing implantable brain-computer interfaces for people with paralysis and vision loss.
Startup Health3 shared keywordsStartUp Health operates a private global membership community for health innovators — including founders, healthcare executives, investors, and clinicians — offering a member network app, live AMAs and fireside chats, in-person event access, and a content library. It focuses on connecting and supporting people working on digital health and healthcare innovation.
NeuroBlade3 shared keywordsNeuroBlade builds SPU (data analytics accelerator) technology delivered as PCIe cards or accelerated cloud instances to speed up query processing for AI/ML workloads. It targets organizations running data analytics and preparation in the cloud or on-premises, integrating with tools like ClickHouse and AWS F2 instances to reduce total cost of ownership.</parameter> <parameter name="founders">[]

Companies competing with Neuralight for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

NeuraLight — Health Tech & Life Sciences | Finderfinder.startupnationcentral.org · Apr 2023Israeli Startup NeuraLight Raises $25M For Its AI Neurological Platformnocamels.com · May 2022NeuraLight secures $25 million Series A to develop precision medicine for neurological diseases | CTechcalcalistech.com · May 2022NeuraLight launches from stealth, raises $5.5 million to digitize neurology - CTechcalcalistech.com · Oct 2021NeuraLight Raises $5.5M in Seed Funding - FinSMEsfinsmes.com · Oct 2021NeuraLight emerges from stealth with $5.5M to digitize neurological evaluation and care | TechCrunchtechcrunch.com · Oct 2021

Frequently asked questions

What does Neuralight do?
NeuraLight develops AI-powered digital biomarkers for neurological diseases including Alzheimer's, Parkinson's, and multiple sclerosis. The company uses signal processing and computer vision to enable clinical assessment and disease monitoring for healthcare providers and medical institutions.
Who founded Neuralight?
Neuralight was founded by Edmund Ben-Ami, Edmund Benami, Gil Shklarski in 2021.
Who are Neuralight's investors?
Neuralight's investors include MS&AD Ventures, Breyer Capital, Koch Disruptive Technologies, Samsung Next, Kli Capital, Operator Partners, Tuesday Capital, VSC Ventures.
How much funding has Neuralight raised?
Neuralight has disclosed $30.5M raised across 2 rounds.
Where is Neuralight headquartered?
Neuralight is headquartered in Tel Aviv, IL.